Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-26

Clinical Trial Update: Denosumab in Subjects With Giant Cell Rich Tumors of Bone [Phase 2]

View source ↗

Summary

Phase 2 trial update for denosumab in subjects with giant cell-rich bone tumors, including aneurysmal bone cysts and giant cell granuloma, with several other be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Aneurysmal Bone Cysts, Giant Cell Granuloma | Phase 2 | Status: UNKNOWN